
Microbot Medical Inc.: updates and filings
Price
$0.68
November 20, 2026Market cap $46M
What Ploutos Investor adds for Microbot Medical
Part of Ploutos Investor, €9.99 a month
- The full history: 16 fiscal years, from 2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 31% since Nov 13, 2026, when the 10-Q these figures come from was filed ($0.98 then, $0.68 on Nov 20, 2026). The figures date from before that move.10-Q
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
June 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Regulation FD disclosureForm8-K
- Nov 13, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 5, 2026Regulation FD disclosure, other material eventsForm8-K
- Nov 3, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Nov 3, 2026Additional annual meeting materialFormDEFA14A
- Nov 3, 2026Annual meeting proxy statementFormDEF 14A
- Oct 27, 2026Regulation FD disclosureForm8-K
- Oct 23, 2026Regulation FD disclosureForm8-K
- Oct 20, 2026Material eventForm8-K
- Oct 6, 2026Regulation FD disclosureForm8-K
- Sep 28, 2026Regulation FD disclosureForm8-K
- Aug 11, 2026Regulation FD disclosureForm8-K
- Aug 11, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 7, 2026Material agreement entered, officer or director changeForm8-K
- Jul 21, 2026Regulation FD disclosureForm8-K
- Jul 7, 2026Regulation FD disclosure, other material eventsForm8-K
- Jun 30, 2026Regulation FD disclosure, other material eventsForm8-K
- Jun 25, 2026Regulation FD disclosureForm8-K
- Jun 23, 2026Regulation FD disclosure, other material eventsForm8-K
- Jun 16, 2026Regulation FD disclosureForm8-K
- Jun 9, 2026Regulation FD disclosure, other material eventsForm8-K
- Jun 2, 2026Regulation FD disclosure, other material eventsForm8-K
- May 26, 2026Regulation FD disclosure, other material eventsForm8-K
- May 15, 2026Regulation FD disclosureForm8-K
- May 14, 2026Regulation FD disclosure, other material eventsForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | 8-K | Regulation FD disclosure | Document |
| Nov 13, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 5, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Nov 3, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Nov 3, 2026 | DEFA14A | Additional annual meeting material | Document |
| Nov 3, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Oct 27, 2026 | 8-K | Regulation FD disclosure | Document |
| Oct 23, 2026 | 8-K | Regulation FD disclosure | Document |
| Oct 20, 2026 | 8-K | Material event | Document |
| Oct 6, 2026 | 8-K | Regulation FD disclosure | Document |
| Sep 28, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 11, 2026 | 8-K | Regulation FD disclosure | Document |
| Aug 11, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 7, 2026 | 8-K | Material agreement entered, officer or director change | Document |
| Jul 21, 2026 | 8-K | Regulation FD disclosure | Document |
| Jul 7, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Jun 30, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Jun 25, 2026 | 8-K | Regulation FD disclosure | Document |
| Jun 23, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Jun 16, 2026 | 8-K | Regulation FD disclosure | Document |
| Jun 9, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Jun 2, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| May 26, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| May 15, 2026 | 8-K | Regulation FD disclosure | Document |
| May 14, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 14, 1994. Of its note and share prospectuses (424B, FWP), the newest 40 of 104.
The full analysis
What do Microbot Medical's filings show?
The filings are where every one of Microbot Medical's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.